Diffuse large B-cell lymphoma: An immunohistochemical approach to diagnosis

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is the most prevalent subtype of non-Hodgkin's lymphoma (NHL), comprising 30%-40% of all cases.
• Accurate NHL subtype classification is crucial for determining prognosis and guiding treatment strategies.

Observation:

• Subtype-specific diagnosis, including molecular prognostic indicators, is essential for DLBCL management.
• The interval between diagnosis and treatment initiation significantly impacts clinical factors and outcomes in newly diagnosed DLBCL.

Findings:

• DLBCL requires precise diagnostic categorization due to its aggressive nature and varied clinical behavior.
• Timely histological and immunohistochemical investigations are critical for oral lymphomas.

Implications:

• Expeditious and accurate diagnostic workups are vital for optimizing patient outcomes in DLBCL.
• This emphasizes the need for rapid diagnostic processes in managing aggressive lymphomas, particularly those presenting in the oral cavity.